As a medical professional, what would you like your A1c to be, regardless of your health? 1) 7% 2) 6% 3) 5% 4) 4% 5) 3% Follow the link to see how your response compares to your colleagues'!

Glycolysis: Glucose-6-phosphate not used for direct glycogen synthesis can be metabolized in the glycolytic pathway. About half of the glucose taken up by liver during duodenal glucose absorption will undergo glycolysis to pyruvate. The resulting pyruvate can be used for lipogenesis and amino acid synthesis, lactate production, or cycled back to glucose-6-phosphate for indirect glycogen synthesis.

More rigorous screening called for to mitigate poor outcomes of this common condition.

Study finds fewer T2 patients on exenatide once-weekly reported gastrointestinal adverse events, compared with those on exenatide twice-daily or liraglutide once-daily.

Framingham Heart Study Offspring cohort does not find similar association for sugar-sweetened drinks.

Ralph DeFronzo and his researchers at UT Health at San Antonio announced that they have cured type 1 diabetes.

Study measures effects of apps on weight reduction.

A 62-year-old man presents with type 2 diabetes, hypertension, and albuminuria. His seated BP is 162/104 mm Hg. What's an ideal blood pressure target for this patient? A. 140/90 mm Hg B. 130/80 mm Hg C. 120/70 mm Hg D. 150/80 mm HG Did you get it right? Follow the link to find out!

Should prediabetes be considered a pre-existing condition? Follow the link to share your opinion!

Sanofi’s My Dose Coach app joins other insulin dosing apps recently cleared by the FDA, and new dosing tools from Novo Nordisk/Glooko. Sanofi’s My Dose Coach, a new, under-the-radar mobile app for adjusting basal insulin doses for those on injections, received FDA clearance in late March. A healthcare provider prescribes and sets up the My Dose Coach mobile app so that it can suggest optimized basal insulin injection doses for people with diabetes. The app will use fasting blood glucose and hypoglycemia data and recommend changes in doses if readings are too high or too low. Release date is unknown.